[KPJ] QoQ Annualized Quarter Result on 31-Mar-2020 [#1]

Stock
[KPJ] KPJ HEALTHCARE BHD
Announcement Date
10-Jun-2020
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2020
Quarter
31-Mar-2020 [#1]
Profit Trend
QoQ- -27.08%
YoY- -1.52%
Quarter Report
Latest QR
Upcoming QR
KPJ's Result
KPJ's Financial Summary
View:
Show?
Annualized Quarter Result
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
Revenue 2,397,443 3,148,654 3,021,566 3,536,636 3,604,364 3,495,834 3,430,880 -21.16%
PBT 150,810 173,584 148,110 220,348 275,393 271,306 266,128 -31.40%
Tax -39,998 -57,525 -45,176 -58,212 -48,696 -90,094 -91,746 -42.35%
NP 110,812 116,058 102,934 162,136 226,697 181,212 174,382 -25.98%
-
NP to SH 110,443 113,544 102,380 154,132 211,368 169,824 161,910 -22.42%
-
Tax Rate 26.52% 33.14% 30.50% 26.42% 17.68% 33.21% 34.47% -
Total Cost 2,286,631 3,032,596 2,918,632 3,374,500 3,377,667 3,314,622 3,256,498 -20.91%
-
Net Worth 1,968,474 1,882,887 1,840,094 1,840,090 1,836,675 1,640,999 1,684,083 10.91%
Dividend
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
Div 51,351 45,645 68,468 85,585 85,426 86,368 86,363 -29.17%
Div Payout % 46.50% 40.20% 66.88% 55.53% 40.42% 50.86% 53.34% -
Equity
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
Net Worth 1,968,474 1,882,887 1,840,094 1,840,090 1,836,675 1,640,999 1,684,083 10.91%
NOSH 4,442,042 4,441,916 4,441,916 4,441,900 4,439,197 4,438,848 4,438,206 0.05%
Ratio Analysis
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
NP Margin 4.62% 3.69% 3.41% 4.58% 6.29% 5.18% 5.08% -
ROE 5.61% 6.03% 5.56% 8.38% 11.51% 10.35% 9.61% -
Per Share
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
RPS 56.02 73.58 70.61 82.65 84.38 80.95 79.45 -20.69%
EPS 2.58 2.65 2.40 3.60 4.95 4.04 3.86 -23.46%
DPS 1.20 1.07 1.60 2.00 2.00 2.00 2.00 -28.75%
NAPS 0.46 0.44 0.43 0.43 0.43 0.38 0.39 11.57%
Adjusted Per Share Value based on latest NOSH - 4,441,900
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
RPS 52.96 69.56 66.75 78.13 79.63 77.23 75.79 -21.16%
EPS 2.44 2.51 2.26 3.41 4.67 3.75 3.58 -22.46%
DPS 1.13 1.01 1.51 1.89 1.89 1.91 1.91 -29.41%
NAPS 0.4349 0.416 0.4065 0.4065 0.4058 0.3625 0.372 10.92%
Price Multiplier on Financial Quarter End Date
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
Date 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 28/06/19 -
Price 1.00 0.85 0.84 0.93 0.945 0.885 0.935 -
P/RPS 1.78 1.16 1.19 1.13 1.12 1.09 1.18 31.36%
P/EPS 38.75 32.04 35.11 25.82 19.10 22.50 24.94 33.96%
EY 2.58 3.12 2.85 3.87 5.24 4.44 4.01 -25.37%
DY 1.20 1.25 1.90 2.15 2.12 2.26 2.14 -31.88%
P/NAPS 2.17 1.93 1.95 2.16 2.20 2.33 2.40 -6.46%
Price Multiplier on Announcement Date
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
Date 18/02/21 30/11/20 28/08/20 10/06/20 26/02/20 28/11/19 30/08/19 -
Price 0.98 0.955 0.83 0.895 0.955 0.905 0.91 -
P/RPS 1.75 1.30 1.18 1.08 1.13 1.12 1.15 32.13%
P/EPS 37.97 35.99 34.69 24.85 19.30 23.01 24.27 34.58%
EY 2.63 2.78 2.88 4.02 5.18 4.35 4.12 -25.76%
DY 1.22 1.12 1.93 2.23 2.09 2.21 2.20 -32.38%
P/NAPS 2.13 2.17 1.93 2.08 2.22 2.38 2.33 -5.78%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment